A Long-term Follow-up Study to Evaluate the Impact of Lumicitabine on the Incidence of Asthma and/or Wheezing in Infants and Children With a History of Respiratory Syncytial Virus Infection
Clinical trial NCT03332459 · COMPLETED
Trial details
- NCT number
- NCT03332459
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-05
- Primary completion
- 2020-04-13
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.